MedTrace Logo

Aspirin Effectiveness Study

NCT01113060 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-12-19

No results posted yet for this study

Summary

Aspirin is an effective medicine for prevention of heart attacks in patients with coronary artery disease and works by preventing clots from forming. In previous studies aspirin has been found to be ineffective in between 2% and 65% of patients but none of these studies have looked specifically at coronary artery disease patients in Ireland. This study is being done to identify the percentage of patients in Ireland whose aspirin is not working effectively and help identify factors that could be used to target interventions to increase aspirin's effectiveness in Irish patients.

Conditions

Sponsors & Collaborators

  • Royal College of Surgeons, Ireland

    lead OTHER

Principal Investigators

  • Prof. Dermot Kenny, MB, BCh, BAO, MD · Royal College of Surgeons, Ireland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01113060 on ClinicalTrials.gov